8 research outputs found
Two jasmonic acid carboxyl methyltransferases in Gossypium hirsutum involved in MeJA biosynthesis may contribute to plant defense
Jasmonic acid (JA) and methyl jasmonate (MeJA), the crucial plant hormones, can induce the emission of plant volatiles and regulate the behavioral responses of insect pests or their natural enemies. In this study, two jasmonic acid carboxyl methyltransferases (JMTs), GhJMT1 and GhJMT2, involved in MeJA biosynthesis in Gossypium. hirsutum were identified and further functionally confirmed. In vitro, recombinant GhJMT1 and GhJMT2 were both responsible for the conversion of JA to MeJA. Quantitative real-time PCR (qPCR) measurement indicated that GhJMT1 and GhJMT2 were obviously up-regulated in leaves and stems of G. hirsutum after being treated with MeJA. In gas chromatography-mass spectrometry (GC-MS) analysis, MeJA treatment significantly induced plant volatiles emission such as (E)-β-ocimene, (Z)-3-hexenyl acetate, linalool and (3E)-4,8-dimethyl-1,3,7-nonatriene (DMNT), which play vital roles in direct and indirect plant defenses. Moreover, antennae of parasitoid wasps Microplitis mediator showed electrophysiological responses to MeJA, β-ocimene, (Z)-3-hexenyl acetate and linalool at a dose dependent manner, while our previous research revealed that DMNT excites electrophysiological responses and behavioral tendencies. These findings provide a better understanding of MeJA biosynthesis and defense regulation in upland cotton, which lay a foundation to JA and MeJA employment in agricultural pest control
Study on the Construction of a Health Lifestyle for Older People in the Longevous Area in China
During the past 40 years of reform and opening-up, China has witnessed great progress in people’s health status. Both the occurrence of diseases and people’s understanding of health have undergone profound changes. Scholars are focusing on changing socioeconomic factors to maintain health lifestyles, and creating healthy “human–land” relations to prevent diseases. From the perspective of health geography, this research conducted field work in Bama, a longevous area in the Guangxi province in China, and applied the theoretical framework of health lifestyles theory to clarify the construction process of health lifestyles for older people in Bama. The roles and characteristics of different social relations in creating health lifestyles are revealed. The findings of this research can provide a new paradigm for China’s health practice research from two aspects: (1) the production of health lifestyles is a knowledge construction process, taking into account the influence of social circumstances, politics, economy, culture, policy, and values; and (2) social attributes affect health lifestyles by reconstructing and improving social relations
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
Abstract Background Traditional Chinese medicine injections (TCMIs) have been widely used to treat severe and acute diseases due to their high bioavailability, accurate curative effect, and rapid effect. However, incidence rates of adverse drug reactions (ADRs) of TCMIs have also increased in recent years. Xueshuantong injection (XSTI) is a commonly-used TCMI comprised of Panax notoginseng total sapiens for the treatment of stroke hemiplegia, chest pain, and central retinal vein occlusion. Its safety remains uncelar. Therefore, post-marketing safety of XSTI was studied in this research. Methods In present study, post-marketing safety surveillance and re-evaluation of XSTI were reported. Thirty thousand eight hundred eighty-four patients in 33 hospitals from 7 provinces participated in this study. Incidence rate, most common clinical manifestations, types, severity, occurrence time, and disposal of ADRs were calculated. Results Incidence rate of ADR of XSTI was 4.14‰ and the most common clinical manifestations were skin and its appendages damage. Type A accounts for 95.49% of ADRs of XSTI and most of them (41.41%) were occurred within 24 h after receiving XSTI treatment. Severities of most ADRs of XSTI were moderate reactions (86.72%). Main disposition of ADRs of XSTI was drug withdrawal and symptomatic treatment (54.69%). Conclusions Our data provide basis for improvement of instructions of XSTI and clinical safety of XSTI. Post-marketing surveillance of TCMIs in this study is a powerful tool to identify types and manifestations of ADRs to improve safety and effectiveness of drugs in clinical applications. Trial registration This protocol has international registration in China clinical trial registration center (ChiCTR~OPC~ 14,005,718) at December 22, 2014
Porous diatomite-mixed 1,4,5,8-NTCDA nanowires as high-performance electrode materials for lithium-ion batteries
Butyl acrylate (BA) and ethylene carbonate (EC) electrolyte additives for low-temperature performance of lithium ion batteries
Influence of π-bridge conjugation on the electrochemical properties within hole transporting materials for perovskite solar cells
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Background: Primary liver cancer, around 75%–85% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people.
Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China in June 2017, which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new edition (2022 Edition) was written by more than 100 experts in the field of liver cancer in China, which not only reflects the real-world situation in China, but also may re-shape the nationwide diagnosis and treatment of liver cancer.
Key Messages: The new guideline aims to encourage the implementation of evidence-based practice, and improve the national average five-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint.